SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland
· Delayed Price · Currency is CHF 2.000
-0.050 (-2.44%)
May 13, 2025, 10:29 AM CET
SHL Telemedicine Revenue
In the year 2024, SHL Telemedicine had annual revenue of $56.78M USD, down -0.52%. SHL Telemedicine had revenue of $28.91M in the half year ending December 31, 2024, with 2.89% growth.
Revenue
$56.78M
Revenue Growth
-0.52%
P/S Ratio
0.65
Revenue / Employee
$107.94K
Employees
526
Market Cap
33.60M CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.78M | -296.00K | -0.52% |
| Dec 31, 2023 | 57.08M | -1.92M | -3.26% |
| Dec 31, 2022 | 59.00M | 9.42M | 18.99% |
| Dec 31, 2021 | 49.58M | 9.42M | 23.45% |
| Dec 31, 2020 | 40.16M | -1.72M | -4.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.40B |
| Novartis AG | 47.05B |
| Lonza Group AG | 6.57B |
| Alcon | 8.98B |
| Galderma Group AG | 4.02B |
| Straumann Holding AG | 2.50B |
| Sandoz Group AG | 9.41B |
| Sonova Holding AG | 3.87B |
SHL Telemedicine News
- 5 months ago - DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care - Business Wire
- 8 months ago - SHL Telemedicine GAAP EPS of -$0.24 misses by $0.07, revenue of $27.9M misses by $1.1M - Seeking Alpha
- 10 months ago - SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire
- 11 months ago - SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
- 1 year ago - SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test - Business Wire
- 1 year ago - SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch - Business Wire
- 1 year ago - SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire
- 1 year ago - Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine's SmartHeart® in Post-ACS Patient Care - Business Wire